TN2010000302A1 - Estradiol-containing drug delivery system - Google Patents
Estradiol-containing drug delivery systemInfo
- Publication number
- TN2010000302A1 TN2010000302A1 TN2010000302A TN2010000302A TN2010000302A1 TN 2010000302 A1 TN2010000302 A1 TN 2010000302A1 TN 2010000302 A TN2010000302 A TN 2010000302A TN 2010000302 A TN2010000302 A TN 2010000302A TN 2010000302 A1 TN2010000302 A1 TN 2010000302A1
- Authority
- TN
- Tunisia
- Prior art keywords
- estradiol
- delivery system
- drug delivery
- containing drug
- active ingredient
- Prior art date
Links
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 title 1
- 238000012377 drug delivery Methods 0.000 title 1
- 229960005309 estradiol Drugs 0.000 title 1
- 229930182833 estradiol Natural products 0.000 title 1
- 239000005584 Metsulfuron-methyl Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- RSMUVYRMZCOLBH-UHFFFAOYSA-N metsulfuron methyl Chemical group COC(=O)C1=CC=CC=C1S(=O)(=O)NC(=O)NC1=NC(C)=NC(OC)=N1 RSMUVYRMZCOLBH-UHFFFAOYSA-N 0.000 abstract 2
- JBDHZKLJNAIJNC-LLVKDONJSA-N clodinafop-propargyl Chemical group C1=CC(O[C@H](C)C(=O)OCC#C)=CC=C1OC1=NC=C(Cl)C=C1F JBDHZKLJNAIJNC-LLVKDONJSA-N 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 230000002363 herbicidal effect Effects 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Reproductive Health (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08002633 | 2008-02-13 | ||
| PCT/EP2009/051303 WO2009101021A2 (en) | 2008-02-13 | 2009-02-05 | Estradiol-containing drug delivery system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2010000302A1 true TN2010000302A1 (en) | 2011-11-11 |
Family
ID=39365963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TN2010000302A TN2010000302A1 (en) | 2008-02-13 | 2010-06-30 | Estradiol-containing drug delivery system |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20110097405A1 (enExample) |
| EP (1) | EP2249803A2 (enExample) |
| JP (1) | JP2011511823A (enExample) |
| KR (1) | KR20100125309A (enExample) |
| CN (1) | CN101945646A (enExample) |
| AR (1) | AR070375A1 (enExample) |
| AU (1) | AU2009214193A1 (enExample) |
| BR (1) | BRPI0908477A2 (enExample) |
| CA (1) | CA2714340A1 (enExample) |
| CL (1) | CL2009000326A1 (enExample) |
| CO (1) | CO6290633A2 (enExample) |
| CR (1) | CR11632A (enExample) |
| DO (1) | DOP2010000252A (enExample) |
| EA (1) | EA201001245A1 (enExample) |
| EC (1) | ECSP10010400A (enExample) |
| IL (1) | IL206640A0 (enExample) |
| MA (1) | MA32073B1 (enExample) |
| MX (1) | MX2010008940A (enExample) |
| NZ (1) | NZ586666A (enExample) |
| PA (1) | PA8816001A1 (enExample) |
| PE (1) | PE20091471A1 (enExample) |
| TN (1) | TN2010000302A1 (enExample) |
| TW (1) | TW200940095A (enExample) |
| UA (1) | UA102680C2 (enExample) |
| UY (1) | UY31660A1 (enExample) |
| WO (1) | WO2009101021A2 (enExample) |
| ZA (1) | ZA201006517B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101310710B1 (ko) * | 2011-03-23 | 2013-09-27 | 한미약품 주식회사 | 오메가-3 지방산 에스테르 및 ＨＭＧ-ＣｏＡ 환원효소 억제제를 포함하는 경구용 복합 조성물 |
| GB201200062D0 (en) | 2012-01-04 | 2012-02-15 | Innotesto Bvba | Estradiol oromucosal liquid compositions |
| AU2012385956B2 (en) | 2012-07-23 | 2017-03-30 | Crayola, Llc | Dissolvable films and methods of using the same |
| HK1247283A1 (zh) * | 2015-03-02 | 2018-09-21 | 科罗纳里康赛普茨有限责任公司 | 用於peg代谢物及peg分解产物检测的化合物及方法 |
| CN119055659A (zh) * | 2024-09-03 | 2024-12-03 | 南通大学 | 17α雌二醇或其化学修饰衍生物在制备预防和/或治疗男性性腺功能低下的药物中的应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4136162A (en) * | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
| JPS56140915A (en) * | 1980-04-07 | 1981-11-04 | Yamanouchi Pharmaceut Co Ltd | Pharmaceutical preparation for solid drug |
| DE3347125A1 (de) * | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption |
| US4764378A (en) * | 1986-02-10 | 1988-08-16 | Zetachron, Inc. | Buccal drug dosage form |
| US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
| US5073374A (en) * | 1988-11-30 | 1991-12-17 | Schering Corporation | Fast dissolving buccal tablet |
| ATE155681T1 (de) * | 1992-05-18 | 1997-08-15 | Minnesota Mining & Mfg | Einrichtung zur transmucosalen wirkstoffabgabe |
| DE4426709A1 (de) * | 1994-07-20 | 1996-01-25 | Schering Ag | Steroidale Sexualhormone enthaltende feste Arzneiformen |
| DE19646392A1 (de) * | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
| CH693255A5 (de) * | 1997-06-13 | 2003-05-15 | Eprova Ag | Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels. |
| CA2329005C (en) * | 1998-04-17 | 2006-01-03 | Ortho-Mcneil Pharmaceutical, Inc. | Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| US6552024B1 (en) * | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
| CH693905A5 (de) * | 1999-04-15 | 2004-04-15 | Eprova Ag | Stabile kristalline Salze von 5-Methyltetrahydrofolsäure. |
| US6264981B1 (en) * | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
| US20030092658A1 (en) * | 2001-02-02 | 2003-05-15 | Meyers Rachel E. | Novel human enzyme family members and uses thereof |
| WO2001077139A1 (de) * | 2000-04-12 | 2001-10-18 | Schering Aktiengesellschaft | 8.beta.-hydrocarbyl-substituierte estratriene als selektiv wirksame estrogene |
| EP1216712A1 (en) * | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Cyclodextrin-drospirenone inclusion complexes |
| EP1390038A2 (en) * | 2001-05-16 | 2004-02-25 | Endeavor Pharmaceuticals | Treatment of conditions relating to hormone deficiencies by administration of progestins |
| CN1473035B (zh) * | 2001-07-27 | 2012-07-18 | 安斯泰来制药有限公司 | 含有口腔内迅速崩解片剂用缓释微粒的组合物及其制造方法 |
| DE10207394B4 (de) * | 2002-02-21 | 2007-03-29 | Lts Lohmann Therapie-Systeme Ag | Geschmacksmaskierte oblatenförmige Arzneizubereitung |
| JP5037779B2 (ja) * | 2002-02-21 | 2012-10-03 | バイエル ファーマ アクチエンゲゼルシャフト | １又は複数のステロイド、１又は複数のテトラヒドロ葉酸成分およびビタミンｂ１２を含む医薬組成物 |
| US20070059346A1 (en) * | 2003-07-01 | 2007-03-15 | Todd Maibach | Film comprising therapeutic agents |
| KR20060126688A (ko) * | 2003-12-09 | 2006-12-08 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 약물-함유 입자 및 그 입자를 함유하는 고형 제제 |
| MY142989A (en) * | 2004-03-10 | 2011-02-14 | Bayer Schering Pharma Ag | Stabilised supersaturated solids of lipophilic drugs |
| US20050220825A1 (en) * | 2004-03-10 | 2005-10-06 | Adrian Funke | Molecular dispersions of drospirenone |
| DE102004023984A1 (de) * | 2004-05-14 | 2005-12-08 | Hf Arzneimittelforschung Gmbh | Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol |
| US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
| DE102005015128B4 (de) * | 2005-03-31 | 2008-12-11 | Bayer Schering Pharma Aktiengesellschaft | Wafer enthaltend Steroidhormone |
| US20060275364A1 (en) * | 2005-05-26 | 2006-12-07 | Ahmed Salah U | Flexible Solid Dosage Forms and Methods of Making and Using the Same |
| DE102005058569B4 (de) * | 2005-12-08 | 2010-07-15 | Lts Lohmann Therapie-Systeme Ag | Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer |
| DE102005062270A1 (de) * | 2005-12-24 | 2007-06-28 | Bayer Technology Services Gmbh | Geschmacksmaskierung von Pulvern |
| DE102006003512A1 (de) * | 2006-01-24 | 2007-08-02 | Bayer Schering Pharma Ag | Plättchenförmige Arzneimittel zur transbukkalen Applikation von Arzneistoffen |
| EP1867321A3 (en) * | 2006-06-07 | 2008-11-19 | Familplan Consulting Ltd. | A pharmaceutical product adapted for oral transmucosal administration comprising a pharmaceutical agent |
| DE102006027796A1 (de) * | 2006-06-16 | 2007-12-20 | Lts Lohmann Therapie-Systeme Ag | Estrogen-Gestagen-Kombinationen |
| DE102006027792A1 (de) * | 2006-06-16 | 2007-12-20 | Lts Lohmann Therapie-Systeme Ag | Antidepressiva-Kombinations-Wafer |
| US20080058272A1 (en) * | 2006-08-29 | 2008-03-06 | Juergen Becker | Nonamer Peptides for Cancer Treatment |
-
2009
- 2009-02-05 CA CA2714340A patent/CA2714340A1/en not_active Abandoned
- 2009-02-05 JP JP2010546291A patent/JP2011511823A/ja not_active Withdrawn
- 2009-02-05 WO PCT/EP2009/051303 patent/WO2009101021A2/en not_active Ceased
- 2009-02-05 NZ NZ586666A patent/NZ586666A/en not_active IP Right Cessation
- 2009-02-05 EP EP09709466A patent/EP2249803A2/en not_active Withdrawn
- 2009-02-05 AU AU2009214193A patent/AU2009214193A1/en not_active Abandoned
- 2009-02-05 KR KR1020107020216A patent/KR20100125309A/ko not_active Withdrawn
- 2009-02-05 MX MX2010008940A patent/MX2010008940A/es unknown
- 2009-02-05 EA EA201001245A patent/EA201001245A1/ru unknown
- 2009-02-05 BR BRPI0908477A patent/BRPI0908477A2/pt not_active IP Right Cessation
- 2009-02-05 CN CN2009801052091A patent/CN101945646A/zh active Pending
- 2009-02-05 US US12/867,409 patent/US20110097405A1/en not_active Abandoned
- 2009-02-10 UA UAA201010636A patent/UA102680C2/ru unknown
- 2009-02-13 UY UY031660A patent/UY31660A1/es not_active Application Discontinuation
- 2009-02-13 PE PE2009000219A patent/PE20091471A1/es not_active Application Discontinuation
- 2009-02-13 PA PA20098816001A patent/PA8816001A1/es unknown
- 2009-02-13 CL CL2009000326A patent/CL2009000326A1/es unknown
- 2009-02-13 AR ARP090100515A patent/AR070375A1/es not_active Application Discontinuation
- 2009-02-13 TW TW098104745A patent/TW200940095A/zh unknown
-
2010
- 2010-06-27 IL IL206640A patent/IL206640A0/en unknown
- 2010-06-30 TN TN2010000302A patent/TN2010000302A1/fr unknown
- 2010-08-12 MA MA33078A patent/MA32073B1/fr unknown
- 2010-08-12 EC EC2010010400A patent/ECSP10010400A/es unknown
- 2010-08-13 CO CO10100017A patent/CO6290633A2/es not_active Application Discontinuation
- 2010-08-13 CR CR11632A patent/CR11632A/es not_active Application Discontinuation
- 2010-08-13 DO DO2010000252A patent/DOP2010000252A/es unknown
- 2010-09-10 ZA ZA2010/06517A patent/ZA201006517B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101945646A (zh) | 2011-01-12 |
| JP2011511823A (ja) | 2011-04-14 |
| EP2249803A2 (en) | 2010-11-17 |
| ECSP10010400A (es) | 2010-09-30 |
| CO6290633A2 (es) | 2011-06-20 |
| CR11632A (es) | 2010-10-05 |
| CA2714340A1 (en) | 2009-08-20 |
| MX2010008940A (es) | 2010-10-05 |
| DOP2010000252A (es) | 2010-08-31 |
| TW200940095A (en) | 2009-10-01 |
| US20110097405A1 (en) | 2011-04-28 |
| WO2009101021A3 (en) | 2009-12-30 |
| ZA201006517B (en) | 2014-02-26 |
| NZ586666A (en) | 2012-04-27 |
| AR070375A1 (es) | 2010-03-31 |
| PE20091471A1 (es) | 2009-10-25 |
| IL206640A0 (en) | 2010-12-30 |
| BRPI0908477A2 (pt) | 2018-03-27 |
| CL2009000326A1 (es) | 2010-07-19 |
| MA32073B1 (fr) | 2011-02-01 |
| PA8816001A1 (es) | 2009-09-17 |
| KR20100125309A (ko) | 2010-11-30 |
| EA201001245A1 (ru) | 2011-04-29 |
| WO2009101021A2 (en) | 2009-08-20 |
| AU2009214193A1 (en) | 2009-08-20 |
| UA102680C2 (ru) | 2013-08-12 |
| UY31660A1 (es) | 2009-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009108077A3 (en) | Pharmaceutical composition for poorly soluble drugs | |
| PL2081547T3 (pl) | Postać galenowa do podawania składników czynnych poprzez śluzówkę | |
| MX2014008020A (es) | Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia. | |
| IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
| WO2012158030A3 (en) | Drug delivery system | |
| UA103025C2 (ru) | Твердая композиция лекарственного средства замедленного высвобождения | |
| MX359288B (es) | Forma iv del clorhidrato de ivabradina. | |
| WO2011005052A8 (en) | Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same | |
| WO2012032337A3 (en) | A transdermal drug administration device | |
| UA97730C2 (ru) | Гербицидные композиции и способ получения гербицидной композиции | |
| MX341015B (es) | Forma de dosificacion de liberacion extendida. | |
| WO2006079928A3 (en) | Polyelectrolyte multilayer film, preparation and uses thereof | |
| WO2012092486A3 (en) | Modified release benzimidazole formulations | |
| GB0715493D0 (en) | Delivery systems for solubilising water-insoluble pharmaceutical active ingredients | |
| WO2012002773A3 (en) | Phenylcarbamate compound and muscle relaxant containing the same | |
| IL201959A (en) | Annals 2 - (1-Acetyl-Piperidine-4-Il) -4,2- Dihydro-Pyrazole-3-On | |
| WO2012172433A3 (en) | A sustained -release composition containing a melanocortin receptor ligand as the active ingredient | |
| WO2012111996A3 (ko) | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 | |
| EP2476420B8 (en) | Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same | |
| HUE041795T2 (hu) | Bevonószer szilárd gyógyszerészeti készítményhez, gyógyszerészeti filmkészítmény, és bevonatos szilárd gyógyszerészeti készítmény | |
| IL195062A0 (en) | Process for the preparation of solid sterile active pharmaceutical ingredient | |
| WO2011159491A3 (en) | Controlled release levetiracetam formulations | |
| TN2010000343A1 (en) | Herbicidal composition | |
| ZA200904563B (en) | Transdermal Therapeutic system for administering water-soluble active ingredients | |
| WO2007022532A3 (en) | Cyclopropyl compounds and compositions for delivering active agents |